Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).

15 May 2013

Study suggests that a blood protein contributes to early development of atherosclerosis

It's on Saturday that the Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI), which suggests for the first time that a blood protein contributes to the early development of atherosclerosis.

14 May 2013

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

Telcare, Inc., the leader in mobile diabetes management solutions, today announced it has received CE Mark approval to market its cellular-enabled blood glucose meter, the first FDA-cleared mHealth glucose meter, in the European Union.

13 May 2013

Children born with CDG don't contain mutation in every cell type, say Sanford-Burnham researchers

Children born with rare, inherited conditions known as Congenital Disorders of Glycosylation, or CDG, have mutations in one of the many enzymes the body uses to decorate its proteins and cells with sugars.

10 May 2013

Quantum International develops medical testing software for Apple iPad

Cutting-edge technology company Quantum International Corp. announced today that it has begun development on an innovative new accessory for the Apple iPad that could potentially revolutionize mobile medical testing.

9 May 2013

Special issue of Gastroenterology presents variety of topics related to pancreas

The editors of Gastroenterology, the official journal of the American Gastroenterological Association Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue.

9 May 2013

PCORI awards $2M to UNC med school for diabetes research

The Patient-Centered Outcomes Research Institute has approved a research award to the University of North Carolina School of Medicine to study the role of glucose monitoring in patients with type 2 diabetes using oral medications.

9 May 2013

New therapeutic targets for reducing heart disease in people with type 1 diabetes

Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque.

8 May 2013

HSPH researchers discover potential target to treat type 2 diabetes and other metabolic diseases

Harvard School of Public Health (HSPH) researchers have discovered that a particular type of protein (hormone) found in fat cells helps regulate how glucose (blood sugar) is controlled and metabolized (used for energy) in the liver.

8 May 2013

Viewpoints: Medicaid's effect on health debated; Young adults central to lowering anxiety about online marketplaces

A study comparing low-income people in Oregon who received access to Medicaid over the past two years with those who did not, found that those on Medicaid visited doctors and hospitals more often, suffered less from depression and were more financially secure.

8 May 2013

Researchers develop injectable nano-network to control blood-sugar levels

In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.

4 May 2013

Lund researchers develop new mouse model to better understand type 2 diabetes in humans

Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment.

3 May 2013

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

EPAC stands for exchange protein activated by cyclic AMP (cAMP). cAMP is an (among many) intracellular messenger molecule. cAMP is generated when certain hormones stimulate a cell by binding to their receptor, which is at the outside surface of the cell.

3 May 2013

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the launch of an educational campaign designed to provide healthcare professionals with a greater understanding of the role sodium glucose co-transporters play in maintaining blood sugar balance, or glucose homeostasis.

3 May 2013

LAP-BAND-weight loss procedure safe and effective for obese people

The LAP-BAND- weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.

2 May 2013

Lund University research opens door to diabetes treatment

A Lund University research team has shed new light on why gastric bypass often sends diabetes into remission rapidly, opening the door to developing treatment with the same effect.

2 May 2013

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Acute pancreatitis is an inflammation of the pancreas which leads to leakage of pancreatic enzymes. Apart from certain drugs such as GLP-1 based therapies, the most common causes of pancreatitis are Gallstones and Alcohol use.

30 Apr 2013

Nephropathy risk lowered by glucose, BP control in Type 1 diabetes

Individuals with Type 1 diabetes should keep good control of their blood sugar levels and blood pressure to reduce their risk for developing nephropathy, say researchers.

29 Apr 2013

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Oramed Pharmaceuticals Inc., a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013.

29 Apr 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

24 Apr 2013

Blood Sugar News and Research

Further Reading

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

Study suggests that a blood protein contributes to early development of atherosclerosis

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

Children born with CDG don't contain mutation in every cell type, say Sanford-Burnham researchers

Quantum International develops medical testing software for Apple iPad

Special issue of Gastroenterology presents variety of topics related to pancreas

PCORI awards $2M to UNC med school for diabetes research

New therapeutic targets for reducing heart disease in people with type 1 diabetes

HSPH researchers discover potential target to treat type 2 diabetes and other metabolic diseases

Viewpoints: Medicaid's effect on health debated; Young adults central to lowering anxiety about online marketplaces

Researchers develop injectable nano-network to control blood-sugar levels

Lund researchers develop new mouse model to better understand type 2 diabetes in humans

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

LAP-BAND-weight loss procedure safe and effective for obese people

Lund University research opens door to diabetes treatment

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Nephropathy risk lowered by glucose, BP control in Type 1 diabetes

Oramed to report results of T1DM oral insulin formulation at Diabetes Summit 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News